Full Press Release Details
2.7, 3.10.3, 3.10.4, 3.10.5
for quotation of additional securities
or documents not available now must be given to ASX as soon as available.
Information and documents given to ASX become ASX's property and may be made
1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001,
11/3/2002, 1/1/2003.
| Name of E ntity: |
| Prana Biotechnology Limited (ASX:PBT) |
| ABN : |
| 37 080 699 065 |
entity) give ASX the following information.
must complete the relevant sections (attach sheets if there is not enough
| 1 | + Class of + securities issued or to be issued | Ordinary Shares (PBT) | |
| 2 | Number of + securities issued or to be issued (if known) or maximum number which may be issued | 39,284 | |
| 3 | Principal terms of the + securities (eg, if options, exercise price and expiry date; if partly paid + securities, the amount outstanding and due dates for payment; if + convertible securities, the conversion price and dates for conversion) | Pari Passu with existing ordinary shares (PBT) |
chapter 19 for defined terms.
| 4 | Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities? If the additional securities do not rank equally, please state: the date from which they do the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment | Yes (PBT) | |
| 5 | Issue price or consideration | $ Nil | |
| 6 | Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets) | Exercise of options (exercised at nil consideration on or before 31.12.2011) |
| 7 | Dates of entering + securities into uncertificated holdings or despatch of certificates | 25 th June 2008 | ||
| Number | + Class | |||
| 8 | Number and + class of all +securities quoted on ASX ( including the securities in clause 2 if applicable) | 201,800,240 | Ordinary Shares (PBT) |
chapter 19 for defined terms.
not quoted on ASX (including
securities in clause 2 if applicable)
| ASX Code | Number | Class of Securities | Issued under an ESOP | |||||||
| Security Type | Exercise Price | Expiry Date | ||||||||
| PBTAM | 3,320,000 | Unlisted warrants | US$8.00 per warrant into 1 ADR (PRAN) (1 ADR = 10 Ordinary Shares (PBT)) | 4 June 2009 | - | |||||
| PBTAK | 380,000 | Unlisted Options | US$5.00 per option into 1 ADR (PRAN) (1 ADR = 10 Ordinary Shares (PBT)) | 17 Dec 2012 | 2004 US ADS Plan | |||||
| PBTAW | 2,677,500 | Unlisted Options | $Nil | 30 June 2010 | 2004 ASX Plan | |||||
| PBTAA | 4,352,893 | Unlisted Options | AUD$0.446 | 30 Nov 2009 | - | |||||
| PBTAB | 1,250,000 | Unlisted Options | $Nil | 7 Aug 2014 | 2004 ASX Plan | |||||
| PBTAC | 2,200,000 | Unlisted Options | $Nil | 31 July 2009 | 2004 ASX Plan | |||||
| PBTAD | 382,756 | Unlisted Options | $Nil | 31 Dec 2011 | 2004 ASX Plan | |||||
| PBTAZ | 5,395,112 | Unlisted Options | AUD$0.370 | 31 Oct 2010 | - | |||||
| PBTAI | 5,395,112 | Unlisted Options | AUD$0.430 | 30 Nov 2010 | - | |||||
| PBTAE | 400,000 | Unlisted Options | AUD$0.285 | 17 Dec 2008 | 2004 ASX Plan | |||||
| PBTAF | 877,592 | Unlisted Options | $Nil | 31 Oct 2010 | 2004 ASX Plan | |||||
| PBTAG | 2,400,000 | Unlisted Options | AUD$0.30 | 31 Oct 2010 | 2004 ASX Plan |
See chapter 19 for defined terms.
2 - Bonus issue or pro rata issue
| 11 | Is security holder approval required? | ||
| 12 | Is the issue renounceable or non-renounceable? | ||
| 13 | Ratio in which the + securities will be offered | ||
| 14 | + Class of + securities to which the offer relates | ||
| 15 | + Record date to determine entitlements | ||
| 16 | Will holdings on different registers (or subregisters) be aggregated for calculating entitlements? | ||
| 17 | Policy for deciding entitlements in relation to fractions | ||
| 18 | Names of countries in which the entity has + security holders who will not be sent new issue documents Note: Security holders must be told how their entitlements are to be dealt with. Cross reference: rule 7.7. | ||
| 19 | Closing date for receipt of acceptances or renunciations | ||
| 20 | Names of any underwriters | ||
| 21 | Amount of any underwriting fee or commission | ||
| 22 | Names of any brokers to the issue | ||
| 23 | Fee or commission payable to the broker to the issue |
chapter 19 for defined terms.
| 24 | Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of + security holders | ||
| 25 | If the issue is contingent on + security holders' approval, the date of the meeting | ||
| 26 | Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent to persons entitled | ||
| 27 | If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders | ||
| 28 | Date rights trading will begin (if applicable) | ||
| 29 | Date rights trading will end (if applicable) | ||
| 30 | How do + security holders sell their entitlements in full through a broker? | ||
| 31 | How do + security holders sell part of their entitlements through a broker and accept for the balance? | ||
| 32 | How do + security holders dispose of their entitlements (except by sale through a broker)? | ||
| 33 | + Despatch date |
chapter 19 for defined terms.
3 - Quotation of securities
need only complete this section if you are applying for quotation of
| 34 | Type of securities ( tick one ) | |
| (a) | x | Securities described in Part 1 |
that have ticked box 34(a)
securities forming a new class of securities
| 35 | If the + securities are + equity securities, the names of the 20 largest holders of the additional + securities, and the number and percentage of additional + securities held by those holders | |
| 36 | If the + securities are + equity securities, a distribution schedule of the additional + securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over | |
| 37 | A copy of any trust deed for the additional + securities |
that have ticked box 34(b)
| 38 | Number of securities for which + quotation is sought | ||
| 39 | Class of + securities for which quotation is sought |
chapter 19 for defined terms.
| 40 | Do the + securities rank equally in all respects from the date of allotment with an existing + class of quoted + securities? If the additional securities do not rank equally, please state: the date from which they do the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment | |||
| 41 | Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another security, clearly identify that other security) | |||
| Number | + Class | |||
| 42 | Number and + class of all + securities quoted on ASX ( including the securities in clause 38) |
chapter 19 for defined terms.
entity may need to obtain appropriate warranties from subscribers for the
securities in order to be able to give this warranty
| Sign Here: | Date: Wednesday 25th June 2008 | |
| Company Secretary |
| The CFO Solution | www.thecfo.com.au |
| 25.06.2008 |
chapter 19 for defined terms.